Arovella Therapeutics LimitedASX: ALA

Positive FDA Type D Meeting Outcome

Oct 28, 2025 at 2:07 AM UTC

Arovella Therapeutics Ltd has released a press release.

View Attachment

Earlier from Arovella Therapeutics

CLDN18.2 CAR-T cells eliminate pancreatic cancer cellsOct 2, 2025

All Arovella Therapeutics news releases